11.Absfrontpageduality ADA 13.Indd
Total Page:16
File Type:pdf, Size:1020Kb
PRESENTED AND PUBLISHED ABSTRACTS DISCLOSURE INFORMATION All presenters/authors are required to disclose to the program audience any fi nancial relationships related to the subject matter of this program. The intent of this disclosure is not to prevent a presenter or author from being involved in the activity, but rather to provide participants with information on which they may make their own judgments. AUTHOR DISCLOSURE A829 AUTHOR DISCLOSURE A830 ABSTRACT AUTHOR DISCLOSURE INFORMATION AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY Aakhus, Svend ...................................... Disclosed no confl ict of interest. Adhami, Anwar .................................... Disclosed no confl ict of interest. Aalgur, Fusun ........................................Disclosed no confl ict of interest. Adhami, Mitra ......................................Disclosed no confl ict of interest. Aamidor, Sarah E. .................................Disclosed no confl ict of interest. Adhya, Sumona .................................... Employee: Medtronic Abayomi, Julie ..................................... Disclosed no confl ict of interest. Adkins, Laura ........................................ Disclosed no confl ict of interest. Abbas, Afroze .......................................Disclosed no confl ict of interest. Adler, Benjamin ....................................Disclosed no confl ict of interest. Abbasi, Fahim ....................................... Disclosed no confl ict of interest. Adler, Steffen ....................................... Consultant: Sanofi Abbate, Antonio ...................................Disclosed no confl ict of interest. Admane, Karim ..................................... Employee: Sanofi Abbott, Caroline A. ............................... Disclosed no confl ict of interest. Admiraal, Wanda ................................. Disclosed no confl ict of interest. Abbott, Scott ........................................ Employee: Valeritas, LLC; Stock/Shareholder: Valeritas, LLC Adorini, Luciano ................................... Disclosed no confl ict of interest. Abcouwer, Steven F. .............................Disclosed no confl ict of interest. Adu, Akosua .........................................Disclosed no confl ict of interest. Abdella, A. ............................................ Disclosed no confl ict of interest. Advani, Andrew .................................... Disclosed no confl ict of interest. Abdella, Nabilla ................................... Disclosed no confl ict of interest. Advani, Suzanne L. ...............................Disclosed no confl ict of interest. Abdelmoneim, Ahmed .......................... Disclosed no confl ict of interest. Afanasyev, Dmitry E. ............................Disclosed no confl ict of interest. Abdel-Rasoul, Mahmoud ..................... Disclosed no confl ict of interest. Afek, Arnon .......................................... Disclosed no confl ict of interest. Abdi, Reza ............................................Disclosed no conflict of interest. Affres, Hélène ......................................Disclosed no confl ict of interest. Abdul Karim, Siti Nurhannah ...............Disclosed no confl ict of interest. Afi k, Shaked ......................................... Disclosed no confl ict of interest. Abdul Shakoor, Shaikh Abdul ...............Disclosed no confl ict of interest. Afi nbinder, Yefi m .................................. Disclosed no confl ict of interest. Abdul-Ghani, Muhammad A. ............... Disclosed no confl ict of interest. Agarwal, Ulka ....................................... Disclosed no confl ict of interest. Abdul-Hay, Samer O. ............................Disclosed no confl ict of interest. Agatsuma, Kumiko ...............................Disclosed no confl ict of interest. Abduljalil, Amir .................................... Disclosed no confl ict of interest. Agenor, Keesandra ...............................Disclosed no confl ict of interest. Abdulreda, Midhat H. ........................... Disclosed no confl ict of interest. Aggarwal, Sandeep .............................. Disclosed no confl ict of interest. Abe, Hiroko ........................................... Disclosed no confl ict of interest. Agha, Amar .......................................... Disclosed no confl ict of interest. Abe, Kiwamu ........................................Disclosed no confl ict of interest. Agne, April A. .......................................Disclosed no confl ict of interest. Abe, Yoshimi ........................................ Disclosed no confl ict of interest. Agosti, Barbara .................................... Disclosed no confl ict of interest. Abel, E. Dale ......................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Agrawal, Pratik ..................................... Employee: Medtronic Merck; Speaker’s Bureau: Merck Ågren, Anna ......................................... Disclosed no confl ict of interest. Aberer, Felix ......................................... Other Relationship: CeQur, Ltd., Menarini, Novo Nordisk A/S Aguer, Celine ........................................Disclosed no confl ict of interest. Abernethy, Gillian ................................. Disclosed no confl ict of interest. Aguiar, Carlos .......................................Disclosed no confl ict of interest. Abiko, Atsuko .......................................Disclosed no confl ict of interest. Aguiar, Fernanda M. .............................Disclosed no confl ict of interest. Abood, Beth .......................................... Disclosed no confl ict of interest. Aguilar Velazquez, Daniela .................. Disclosed no confl ict of interest. AUTHOR DISCLOSURE Abou-Samra, Abdul B. .......................... Disclosed no confl ict of interest. Aguilar, David .......................................Disclosed no confl ict of interest. Abraham, Mona A. ...............................Disclosed no confl ict of interest. Aguilar, Montserrat ..............................Disclosed no confl ict of interest. Abraham, Prakash ................................Disclosed no confl ict of interest. Aguilar-Diosdado, Manuel ................... Research Support: Amylin Pharmaceuticals, Inc. (Spouse/ Abrahamian, Gregory ...........................Disclosed no confl ict of interest. Partner) Abrahamson, Martin J. ........................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc., Ah Kioon, Marie Dominique ................. Disclosed no confl ict of interest. Halozyme Therapeutics, Novo Nordisk, Inc.; Consultant: Ahdal, Jaishid ...................................... Disclosed no confl ict of interest. WebMD Ahima, Rexford S. ................................ Disclosed no confl ict of interest. Abramson, Natalie ...............................Disclosed no confl ict of interest. Ahmad, Jamal ......................................Disclosed no confl ict of interest. Abreu, Cristina ..................................... Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Eli Lilly Ahmann, Andrew ................................. Disclosed no confl ict of interest. and Company, Novo Nordisk A/S, Sanofi Ahmeti, Irfan ........................................ Disclosed no confl ict of interest. Abreu, Gabriela ....................................Disclosed no confl ict of interest. Ahn, Chul Woo ..................................... Disclosed no confl ict of interest. Abreu, Marconi .................................... Disclosed no confl ict of interest. Ahn, Jae Hee ........................................ Disclosed no confl ict of interest. Absher, Devin ....................................... Disclosed no confl ict of interest. Ahn, Ki Yong .........................................Disclosed no confl ict of interest. Abt, Markus .......................................... Employee: Hoffman La Roche Ahn, Kyu Jeung ....................................Disclosed no confl ict of interest. Abuaysheh, Sanaa ............................... Disclosed no confl ict of interest. Ahn, So-Yeon ........................................ Disclosed no confl ict of interest. Abudukadier, Abulizi ............................ Disclosed no confl ict of interest. Ahn, SunHee ........................................ Disclosed no confl ict of interest. Aburatani, Hiroyuki .............................. Disclosed no confl ict of interest. Ahn, Sylvie A. .......................................Disclosed no confl ict of interest. Acar, Ramazan ......................................Disclosed no confl ict of interest. Ahn, Yu-Bae ..........................................Disclosed no confl ict of interest. Accili, Domenico .................................. Consultant: Amgen, Inc., Eli Lilly and Company; Research Ahrén, Bo .............................................. Advisory Panel: GlaxoSmithKline, Novartis Pharmaceuticals Support: AstraZeneca Pharmaceuticals LP, Merck Corporation, Sanofi ; Speaker’s Bureau: Merck, Novartis Acerini, Carlo L. ....................................Disclosed no confl ict of interest. Pharmaceuticals Corporation; Stock/Shareholder: Novo Acharya, Nikhil .....................................Disclosed no confl ict of interest. Nordisk A/S Achilike, Immculeta U. .........................Disclosed no confl ict of interest. Aibiki, Mayo .........................................Disclosed no confl ict of interest. Ackard, Diann .......................................Disclosed no confl ict of interest. Aiello, Lloyd P. ...................................... Consultant: Abbott Laboratories, Inc., Genentech, Genzyme Ackart,